Using a series of cell functional experiments, our data showed that exosomes-derived miR-154-5p could inhibit the progression and angiogenesis of ESCC through directly targeting KIF14, which might be a novel approach for the diagnosis and treatment of ESCC. The gene discussed is KIF14; the disease is esophageal squamous cell carcinoma.